Hyperledger Project Explores Fighting Counterfeit Drugs with Blockchain
Hyperledger project member Accenture has proposed using blockchain tech to fight the spread of counterfeit drugs.

At a working group meeting of the Hyperledger blockchain project today, a representative for global professional services company Accenture pitched the early phases of a project designed to fight the spread of counterfeit drugs using blockchain technology.
The details came during a meeting of the initiative's working group focused on project requirements.
Accenture's connected devices software lead Primrose Mbanefo, who works with its Internet of Things business development team and helps produce some of the company’s proofs-of-concept, described how more efficient tracking of medicines using immutable data could improve accountability in the pharmaceutical industry.
Mbanefo said:
"If we could get that data and prove that documents have not been tampered with we could say the drug actually came from the factory that we say it came from."
A key point up for debate at the meeting was the question of defining what exactly constitutes counterfeit activity in the pharmaceutical industry. According to Mbanefo, counterfeiters include both “rogue” manufacturers and established companies around the world that are failing to include the right amounts of active ingredients in medicines – or none at all.
"That would be cleared up if we had a supply chain we could actually trust," she said.
The idea of using distributed time-stamping to differentiate counterfeit drugs is a compelling one, given the success of the trade.
In the United Kingdom, where Mbanefo is based, a counterfeit medicines bust last June resulted in the seizure of 6.2 million doses or medical devices, worth £15.8m. According to the BBC report, a total of £51.6m of counterfeit medical goods around the world were confiscated during that one operation.
The control of the counterfeit drugs problem is just one supply chain-focused use case being looked at by members of the Hyperledger project.
of blockchain in supply chains include tracking the manufacture and assembly of computer components, assessing the quality of milk products shipped and sold and confirming the veracity of food labels.
Photo of pills via Shutterstock
More For You
Protocol Research: GoPlus Security

What to know:
- As of October 2025, GoPlus has generated $4.7M in total revenue across its product lines. The GoPlus App is the primary revenue driver, contributing $2.5M (approx. 53%), followed by the SafeToken Protocol at $1.7M.
- GoPlus Intelligence's Token Security API averaged 717 million monthly calls year-to-date in 2025 , with a peak of nearly 1 billion calls in February 2025. Total blockchain-level requests, including transaction simulations, averaged an additional 350 million per month.
- Since its January 2025 launch , the $GPS token has registered over $5B in total spot volume and $10B in derivatives volume in 2025. Monthly spot volume peaked in March 2025 at over $1.1B , while derivatives volume peaked the same month at over $4B.
More For You
Bitcoin Treads Water Near $90K as Bitfinex Warns of 'Fragile Setup' to Shocks

BTC's relative weakness compared to stocks points to tepid spot demand, making the largest crypto vulnerable to macro volatility, Bitfinex analysts said.
What to know:
- Bitcoin erased very modest overnight gains early Monday and spent the rest of the U.S. session in a tight range around the $90,000 level.
- Rising long bond yields and a small U.S. equities pulling back weighed on risk appetite as traders eye this week's Federal Reserve meeting.
- Bitfinex analysts pointed out bitcoin's relative weakness against U.S. stocks amid modest spot demand and structural softness.











